Harnessing CRISPR/Cas9 technology in cardiovascular disease
Rezaei, Hamzeh; Khadempar, Saedeh; Farahani, Najmeh; Hosseingholi, Elaheh Zadeh; Hayat, Seyed Mohammad Gheibi; Sathyapalan, Thozhukat; Sahebkar, Amir Hossein
Elaheh Zadeh Hosseingholi
Seyed Mohammad Gheibi Hayat
Amir Hossein Sahebkar
The CRISPR/Cas9 system is a precisely targeted bacterial defense system, used to control invading viruses. This technology has many potential applications including genetic changes in somatic and germ cells and the creation of knockout animals. Compared to other genome editing techniques such as zinc-finger nucleases and transcription activator-like effector nucleases (TALENS), the CRISPR/Cas9 system is much easier and more efficient. Most importantly, the multifunctional capacity of this technology allows simultaneous editing of several genes. The CRISPR/Cas9 system also potentially has the ability to prevent and treat human diseases. The present article addresses some key points related to the use of the CRISPR/Cas9 system as a powerful tool in cardiovascular research and as a new strategy for the treatment of cardiovascular disease (CVD).
|Journal Article Type||Article|
|Journal||Trends in Cardiovascular Medicine|
|Peer Reviewed||Peer Reviewed|
|APA6 Citation||Rezaei, H., Khadempar, S., Farahani, N., Hosseingholi, E. Z., Hayat, S. M. G., Sathyapalan, T., & Sahebkar, A. H. (in press). Harnessing CRISPR/Cas9 technology in cardiovascular disease. Trends in Cardiovascular Medicine, https://doi.org/10.1016/j.tcm.2019.03.005|
|Keywords||CRISPR/Cas9; Genome editing; Cardiovascular disease|
|Additional Information||This is the accepted manuscript of an article published in Trends in cardiovascular medicine, 2019. The version of record is available at the DOI link in this record.|
©2020, Elsevier. This manuscript version is made available under the CC-BY-NC-ND 4.0 license http://creativecommons.org/licenses/by-nc-nd/4.0/
You might also like
Renin-Angiotensin System Overactivation in Type 2 Diabetes: A Risk for SARS-CoV-2 Infection?
The role of interleukin-18 in the development and progression of atherosclerosis